Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.75 GBp
Change Today +0.63 / 29.41%
Volume 8.4M
As of 12:15 PM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

phorm corp ltd (PHRM) Snapshot

Open
2.38 GBp
Previous Close
2.13 GBp
Day High
2.75 GBp
Day Low
1.88 GBp
52 Week High
09/22/14 - 12.25 GBp
52 Week Low
07/3/15 - 1.88 GBp
Market Cap
23.2M
Average Volume 10 Days
2.2M
EPS TTM
-0.08 GBp
Shares Outstanding
843.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHORM CORP LTD (PHRM)

Related News

No related news articles were found.

phorm corp ltd (PHRM) Related Businessweek News

No Related Businessweek News Found

phorm corp ltd (PHRM) Details

Phorm Corporation Limited, a personalization technology company, engages in behavioral and contextual online advertising activities. The company offers Open Internet Exchange platform to provide a source of keyword text advertising across various categories, as well as control of performance parameters, such as recency and frequency. It primarily serves Internet service providers, publishers, ad networks, and advertisers. The company has operations in China, Russia, Singapore, Turkey, the United Kingdom, and the United States. Phorm Corporation Limited was incorporated in 2012 and is based in Singapore.

Founded in 2012

phorm corp ltd (PHRM) Top Compensated Officers

Founder, Chairman and Chief Executive Officer...
Total Annual Compensation: $550.0K
Group Chief Operating Officer, Chief Financia...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

phorm corp ltd (PHRM) Key Developments

Phorm Corporation Limited Announces Revenue Results for the Second Quarter of 2015

Phorm Corporation Limited announced revenue results for the second quarter of 2015. For the quarter, the company's total revenues were RUB 29.0 million compared with RUB 15.7 million for the first quarter of 2015. The growth in revenue is based on demonstrating the performance of the platform to the advertisers through a series of paid for test campaigns.

Phorm Appoints Michael Alkin as a Non-Executive Director

Phorm announced the appointment of Mr. Michael Alkin as a Non-Executive Director of the Company with immediate effect. Mr. Alkin is currently a Portfolio Manager of the Tullamore Fund at Hilton Capital Management, LLC. Prior to joining Hilton Capital, Mr. Alkin worked for 17 years in the hedge fund industry, most recently as a Portfolio Manager at Kellner Capital, having previously spent 7 years at Knott Partners LP as a Senior Partner of its USD 1.5 billion equity hedge fund.

Phorm Corporation Limited Reports Audited Consolidated Earnings Results and Company Cash Flow Results for the Year Ended December 31, 2014

Phorm Corporation Limited reported audited consolidated earnings results for the year ended December 31, 2014. For the period, the company reported revenue of $351,054 against of $279,750 for the same period a year ago. Operating loss was $37.9 million (excluding share based payment expense) against of $35.1 million in 2013. Total revenue was $0.4 million was generated for the year ended 31 December 2014 against of $0.3 million in 2013. Operating loss after share based payment expense was $40,178,585 compared to $45,861,453 a year ago. Loss before tax after share based payment expense was $40,487,416 compared to $46,603,666 a year ago. Loss for the year was $40,487,416 compared to $46,603,666 a year ago. Loss attributable to equity holders of the company was $47,899,979 compared to $46,603,666 a year ago. Basic and diluted loss per share was $0.08 compared to $0.16 a year ago. Net cash used in operating activities was $40,193,929 compared to $33,111,197 a year ago. Purchase of plant and equipment was $723,533 compared to $1,598,054 a year ago. For the period, on a company basis, the company reported net cash used in operating activities of $115,394 compared to $2,218,439 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:LN 2.75 GBp +0.63

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies
 

Industry Analysis

PHRM

Industry Average

Valuation PHRM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 817.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHORM CORP LTD, please visit www.phorm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.